Tom van Wijk

Tom van Wijk, Abbott Healthcare Products B.V. - Qepler Summits And Conferences

Tom van Wijk

Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis
Abbott Healthcare Products B.V.
Weesp, The Netherlands
At Abbott, we help people live fully with our life-changing technology. We keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health. This is technology at its most personal, the kind that helps you live healthier so you can do the things you love.

Tom van Wijk is a principal Scientist with over 20 years of experience in pharmaceutical analysis.

Supporting established marketed products at Abbott Healthcare Products in the Analytical Science and Technology Department in Weesp (the Netherlands). Specialized in small molecule impurity profiling, mass spectrometry and method development for the active materials as well as the formulated products.

One of his key interests is developing applications and strategies to control trace levels of potential mutagenic impurities, elemental impurities and leachables.

Related Sessions:

Qepler - Genotoxic Impurities in Pharmaceuticals Summit thumbnail Details

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 2: Friday, 12 April 2019
CASE STUDY: Control of toxic impurities in pharmaceutical products.
  • Analytical methods and techniques
  • Analytical strategies, challenges and perspectives
  • Potential for harmonization of approaches to control toxic impurities
View Details
Qepler - 2nd Annual Extractables & Leachables Summit thumbnail Details

2nd Annual Extractables &
Leachables Summit 2020

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 22 Oct 2020
  • Virtual,
  • Pharma
Day 2: Friday, 23 October 2020
CASE STUDY: Analytical strategies for extractables and leachables
  • Analytical technique selection
  • Challenges of coverage of E&L
  • Perspective on E&L analysis
View Details
Qepler - 2nd Genotoxic Impurities in Pharmaceuticals Virtual Summit thumbnail Details

2nd Annual Genotoxic Impurities in
Pharmaceuticals Summit 2021

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 15 Jul 2021
  • Virtual,
  • Pharma
Day 2: Friday, 16 July 2021
CASE STUDY: Assessment of potential mutagenic degradation products.
  • Expectations on degradation products
  • Approaches for assessing degradation products
  • Analytical strategies
View Details
Qepler - 3rd Annual Genotoxic Impurities in Pharmaceuticals Virtual Summit thumbnail Details

3rd Annual Genotoxic Impurities
in Pharmaceuticals Summit 2023

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 09 Mar 2023
  • Virtual,
  • Pharma
Day 2: Friday, 10 March 2023
CASE STUDY: Analytical testing and control approaches for GTIs in drug substance
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.